Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001659075-26-000002
Filed / recorded
Mar 4, 2026, 10:00 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Elevance Health, Inc.
Issuer CIK
1156039
Ticker
ELV
Reporting person
Ronald W Penczek
Relationship
Officer
Officer title
CAO & Controller
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 2, 2026
Transaction code
F
Shares / units
131
Price per share
$294.07
Acquired / disposed
Disposed (D)
Shares owned after
1,743
Ownership form
Direct
Amendment
No
Footnotes from the filing
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan.
A board member of Elevance Health spent $870K of their very own money to buy Elevance Health shares. Their pile of Elevance Health shares grew by 470%.